ABEO
Price
$5.53
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Capitalization
315.18M
59 days until earnings call
Intraday BUY SELL Signals
CADL
Price
$8.56
Change
+$0.40 (+4.90%)
Updated
Jun 12 closing price
Capitalization
627.19M
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABEO vs CADL

Header iconABEO vs CADL Comparison
Open Charts ABEO vs CADLBanner chart's image
ABEO vs CADL Comparison Chart in %
View a ticker or compare two or three
VS
ABEO vs. CADL commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABEO is a StrongBuy and CADL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2026
Stock price -- (ABEO: $5.53 vs. CADL: $8.56)
Brand notoriety: ABEO and CADL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABEO: 90% vs. CADL: 68%
Market capitalization -- ABEO: $315.18M vs. CADL: $627.19M
ABEO [@Biotechnology] is valued at $315.18M. CADL’s [@Biotechnology] market capitalization is $627.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $112.92B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABEO’s FA Score shows that 1 FA rating(s) are green whileCADL’s FA Score has 0 green FA rating(s).

  • ABEO’s FA Score: 1 green, 4 red.
  • CADL’s FA Score: 0 green, 5 red.
According to our system of comparison, ABEO is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABEO’s TA Score shows that 6 TA indicator(s) are bullish while CADL’s TA Score has 5 bullish TA indicator(s).

  • ABEO’s TA Score: 6 bullish, 4 bearish.
  • CADL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ABEO is a better buy in the short-term than CADL.

Price Growth

ABEO (@Biotechnology) experienced а +1.28% price change this week, while CADL (@Biotechnology) price change was +0.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.78%. For the same industry, the average monthly price growth was +90.18%, and the average quarterly price growth was +2050.65%.

Reported Earning Dates

ABEO is expected to report earnings on Aug 12, 2026.

CADL is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (+0.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($627M) has a higher market cap than ABEO($315M). CADL YTD gains are higher at: 51.504 vs. ABEO (4.934). ABEO has higher annual earnings (EBITDA): 73.4M vs. CADL (-50.3M). CADL has more cash in the bank: 195M vs. ABEO (168M). ABEO has less debt than CADL: ABEO (23.2M) vs CADL (49.3M). ABEO has higher revenues than CADL: ABEO (14.5M) vs CADL (0).
ABEOCADLABEO / CADL
Capitalization315M627M50%
EBITDA73.4M-50.3M-146%
Gain YTD4.93451.50410%
P/E Ratio5.82N/A-
Revenue14.5M0-
Total Cash168M195M86%
Total Debt23.2M49.3M47%
FUNDAMENTALS RATINGS
ABEO: Fundamental Ratings
ABEO
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
16
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABEOCADL
RSI
ODDS (%)
Bearish Trend 6 days ago
71%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ABEO
Daily Signal:
Gain/Loss:
CADL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FZAHX267.773.18
+1.20%
Fidelity Advisor Growth Opps Z
HFYSX15.850.14
+0.89%
Hartford Schroders Intl Multi-Cp Val R4
TSCPX13.140.10
+0.77%
AMG TimesSquare Small Cap Growth N
MTINX25.780.13
+0.51%
NYLI Income Builder Investor Class
JIAIX9.890.04
+0.41%
JHancock Multi-Asset High Income I

ABEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABEO has been loosely correlated with AVBP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ABEO jumps, then AVBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABEO
1D Price
Change %
ABEO100%
N/A
AVBP - ABEO
43%
Loosely correlated
+1.13%
IMTX - ABEO
41%
Loosely correlated
+3.53%
SYRE - ABEO
41%
Loosely correlated
+0.02%
KURA - ABEO
41%
Loosely correlated
+2.14%
RGNX - ABEO
40%
Loosely correlated
+6.05%
More

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with AURA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+4.90%
AURA - CADL
45%
Loosely correlated
+3.22%
RXRX - CADL
44%
Loosely correlated
N/A
CRBU - CADL
41%
Loosely correlated
-3.92%
MGX - CADL
40%
Loosely correlated
-4.00%
ABEO - CADL
40%
Loosely correlated
N/A
More